VEGFs, angiopoietins, Ephrins and their receptors: putative targets for tumor therapy?
Marmé
D
D
Institute of Molecular Oncology, Tumor Biology Center, Breisacher Str 117, D-79106 Freiburg, Germany.
D043925:Angiogenesis Inducing Agents / Q000378:metabolism; D000818:Animals; D016228:Endothelial Growth Factors / Q000378:metabolism; D036342:Ephrins / Q000378:metabolism; D006133:Growth Substances / Q000378:metabolism*; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins / Q000378:metabolism; D008222:Lymphokines / Q000378:metabolism; D051379:Mice; D009363:Neoplasm Proteins / Q000378:metabolism; D009369:Neoplasms / Q000098:blood supply / Q000188:drug therapy* / Q000378:metabolism* / Q000473:pathology; D009389:Neovascularization, Pathologic; D011518:Proto-Oncogene Proteins; D036081:Receptors, Eph Family / Q000378:metabolism; D040262:Receptors, Vascular Endothelial Growth Factor / Q000378:metabolism; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D043925:Angiogenesis Inducing Agents; D016228:Endothelial Growth Factors; D036342:Ephrins; D006133:Growth Substances; D036341:Intercellular Signaling Peptides and Proteins; D008222:Lymphokines; C105373:MEN1 protein, human; D009363:Neoplasm Proteins; D011518:Proto-Oncogene Proteins; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D036081:Receptors, Eph Family; D040262:Receptors, Vascular Endothelial Growth Factor